The Hippo Signaling Pathway: A Candidate New Drug Target for Malignant Tumors

Review
In: Innovative Medicine: Basic Research and Development [Internet]. Tokyo: Springer; 2015.

Excerpt

The Hippo pathway has the unique capacity to sense tissue architecture and the external forces that shape it, and dysregulation of this pathway leads to tumorigenesis. The study of mice bearing systemic or tissue-specific mutations of Hippo elements has driven huge progress in understanding this pathway’s role in normal physiology and disease. Here, we summarize how disruption of Hippo signaling relates to cancer, and we highlight the importance of this pathway as a new drug target for malignant tumors.

Publication types

  • Review